# US 2018/0021227 A1 · Compositions and methods for improved skin care

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021227 A1
- Document ID: US20180021227A1
- Status: Published application
- Kind: A1
- Application number: 15/692,708
- Filed: 2017-08-31
- Published: 2018-01-25
- Earliest claimed: 2005-10-03
- Inventors: MARK A. PINSKY
- Web page: https://patentgrep.com/patent/US20180021227A1

## CPC

- A61K 8/14: Liposomes; Vesicles
- A61K 8/65: Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- A61K 31/728: Hyaluronic acid
- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A61P 15/18: Feminine contraceptives
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/02: for chemically bleaching or whitening the skin
- A61Q 19/04: for chemically tanning the skin (topical sun or radiation screening or tanning preparations A61Q17/04)
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Compositions and methods for administering collagen to a human subject have been developed. The collagen-containing lipid vesicles of the invention provide a delivery system for human collagen which eliminates problems associated with chemical and physical instability of the collagen as well as immune responses to non-human collagen.

## Claims

### Claim 1

A liposome comprising at least one component selected from the group consisting of hyaluronic acid and collagen.

### Claim 2 (depends on 1)

The liposome, according to claim 1, comprising hyaluronic acid.

### Claim 3 (depends on 2)

The liposome, according to claim 2, wherein the hyaluronic acid is cross-linked.

### Claim 4 (depends on 2)

The liposome, according to claim 2, wherein the hyaluronic acid is not cross-linked.

### Claim 5 (depends on 1)

The liposome, according to claim 1, wherein the hyaluronic acid is linear hyaluronic acid of less than 500 kDa.

### Claim 6 (depends on 1)

The liposome, according to claim 1, comprising collagen.

### Claim 7 (depends on 6)

The liposome, according to claim 6, wherein the collagen is human collagen.

### Claim 8 (depends on 6)

The liposome, according to claim 6, wherein the collagen is a recombinant collagen.

### Claim 9 (depends on 6)

The liposome, according to claim 6, wherein said collagen is a collagen derivative.

### Claim 10 (depends on 6)

The liposome, according to claim 6, wherein said collagen is a Type I or Type III collagen.

### Claim 11 (depends on 6)

The liposome, according to claim 6, wherein said collagen is in a particle size of less than 800 nm.

### Claim 12 (depends on 6)

The liposome, according to claim 6, wherein said collagen is in the fibril form.

### Claim 13 (depends on 1)

The liposome, according to claim 1, which comprises collagen and hyaluronic acid.

### Claim 14 (depends on 1)

The liposome, according to claim 1, further comprising at least one of the group consisting of desquamation agents, anti-acne agents, anti-wrinkle agents, vitamin B3 compounds, retinoids, hydroxyl acids, anti-oxidants, radical scavengers, chelators, flavonoids, anti-inflammatory agents, anti-cellulite agents, topical anesthetics, tanning agents, skin lightening agents, skin soothing and skin healing agents, antimicrobial and antifungal agents, sunscreen agents, conditioning agents, structuring agents, thickening agent, and preservatives.

### Claim 15 (depends on 1)

The liposome, according to claim 1, which is paucilamellar.

### Claim 16 (depends on 1)

The liposome, according to claim 1, which comprises non-phospholipid surfactants.

### Claim 17

A composition for delivering an agent into the skin of a subject wherein said composition comprises a cyclodextrin having associated therewith the agent, wherein the agent is selected from the group consisting of collagen and hyaluronic acid.

### Claim 18

A method for administering an agent into the skin of a subject, the method comprising the step of contacting the skin of the subject with a composition comprising a carrier comprising a cavity having encapsulated therein an agent selected from the group consisting of collagen and hyaluronic acid, wherein said carrier is a liposome or a cyclodextrin.
